Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in previously untreated chronic hepatitis C genotype 1 patients (Q42259740)
Jump to navigation
Jump to search
scientific article published on 18 November 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in previously untreated chronic hepatitis C genotype 1 patients |
scientific article published on 18 November 2013 |
Statements
1 reference
Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in previously untreated chronic hepatitis C genotype 1 patients (English)
1 reference
Sandrine Cure
1 reference
Florence Bianic
1 reference
Sandra Gavart
1 reference
Geoffrey Dusheiko
1 reference
Steve Curtis
1 reference
Seina Lee
1 reference
18 November 2013
1 reference
1 reference
17
1 reference
1
1 reference
65-76
1 reference
Identifiers
1 reference
1 reference